- Mandible Advancement Devices
- Tongue Stabilizing Devices
- Nasal Devices
- Continuous Positive Airways Pressure Devices
- Chin Straps
- Others
Anti-Snoring Treatment Market is estimated to be valued at USD 4,982.1 million in 2022 and is poised to grow at a significant CAGR of 8.9% over 2023-2029. Snoring is a hoarse sound generated when air rushes through relaxed tissues in the throat, causing friction between the tissues and causing vibrations during breathing. Snoring is a frequent occurrence in the population, but it can be a major health issue for some people. Snoring is commonly associated with a sleep problem known as obstructive sleep apnea (OSA) drugs. The mandible advancement devices segment is anticipated to grow at significant CAGR over the forecast years owing to increased demand mandibular advancement device (MAD) are most widely used mouth device for sleep apnea patients. Mandibular advancement device (MAD) resembles a mouth guard used in sports. Moreover, these devices snap over the upper and lower dental arches and have metal hinges that makes it possible for the lower jaw to move forward. Moreover, rising prevalence of sleep apnea and OSAHS, rise in the geriatric population leading to increasing sleep disorder, which is associated with age, and increasing applications of mandibular advancement devices for treatment of snoring and OSA over CPAP systems.
Anti-Snoring Treatment Market Key Developments:
In February 2021, the United States Food and Drug Administration (US FDA) approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA'', developed by Rotech Healthcare. It delivers electrical muscle stimulation via a mouthpiece that is placed around the tongue.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The rising prevalence of different sleep disorders will drive revenue growth in the global anti-snoring therapy market in the approaching years. According to the American Sleep Association, roughly 50-70 million persons in the United States have a sleep disturbance, with 48 percent reporting snoring. Snoring is believed to affect 40% of women and 57% of men in the United States. Obesity, alcohol intake, sedative prescription usage, chronic nasal congestion, and pregnancy are the key factors leading to the rising incidence of snoring. As a result, increased prevalence and awareness of snoring problems will drive market growth.
The Anti-Snoring Treatment market in North America is likely to hold the highest revenue share of in 2022 and same trend is expected over the forecast period due to the rising obesity rate and the acceptance of unhealthy lifestyles are fuelling the industry's growth. Thus, the availability of a huge untreated population pool, along with increased alcohol and smoking use, which raises the likelihood of developing snoring condition, would boost sales of anti-snoring devices in the region. Moreover, Presence of large number of players and favourable reimbursement policies are also the factors contributing to the growth of the anti-snoring treatment market.
Latin America
Europe
Asia Pacific
Middle East
North America
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.